ArticleScientific reports2016

Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer.

Hitesh Kulhari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.